# Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

Study · id `cardio:ct-nct05069558` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05069558](<https://clinicaltrials.gov/study/NCT05069558>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05069558

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 450 participants.

## Technical summary

Registry record NCT05069558. Randomized; single masking; primary purpose treatment. Start 2022-05-09 (actual); primary completion 2025-11-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 450 participants (planned count; ClinicalTrials.gov record NCT05069558, source copy `cardio:ctgov-nct05069558-2026-10-16`, retrieved 2026-10-26)
- Started: 2022-05-09 (actual) (ClinicalTrials.gov record NCT05069558, source copy `cardio:ctgov-nct05069558-2026-10-16`, retrieved 2026-10-26)
- Primary completion: 2025-11-30 (actual) (ClinicalTrials.gov record NCT05069558, source copy `cardio:ctgov-nct05069558-2026-10-16`, retrieved 2026-10-26)
- Completion: 2029-11 (anticipated) (ClinicalTrials.gov record NCT05069558, source copy `cardio:ctgov-nct05069558-2026-10-16`, retrieved 2026-10-26)
- Countries: United States; Canada; Denmark; Finland; France; Germany; Netherlands; United Kingdom (ClinicalTrials.gov record NCT05069558, source copy `cardio:ctgov-nct05069558-2026-10-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05069558-2026-10-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion
- Acronym: OCCLUFLEX
- Condition: Stroke
- Condition: Patent Foramen Ovale
- Condition: PFO
- Intervention (Device): Investigational PFO Closure Device
- Intervention (Device): Standard of Care PFO Closure Device
- Lead sponsor: Occlutech International AB
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Occlutech International AB (`cardio:org-occlutech-international-ab`)

## Provenance

Content hash: db4cef560ab4b20f6e13a853a7c2c3b0788222eba4a2b8a6cb8a618e08985243
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
